Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of Cardiovascular Risk Factors for Peripheral Artery Disease and Coronary Artery Disease in the Korean Population

  • Jang, Shin Yi (Division of Cardiology, Department of Medicine, Cardiovascular Imaging Center, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Ju, Eun Young (Graduate School of Public Health, Seoul National University) ;
  • Cho, Sung-Il (Graduate School of Public Health, Seoul National University) ;
  • Lee, Seung Wook (Graduate School of Public Health, Seoul National University) ;
  • Kim, Duk-Kyung (Division of Cardiology, Department of Medicine, Cardiovascular Imaging Center, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Published : 2013.05.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: The objective of this study was to analyze and compare risk factors for peripheral artery disease (PAD) and coronary artery disease (CAD). Subjects and Methods: The sample included 7936 Korean patients aged ${\geq}20$ years who were hospitalized from 1994 to 2004. Of the 7936 subjects, PAD (n=415), CAD (n=3686), and normal controls (Control) (n=3835) were examined at the Health Promotion Center, Samsung Medical Center. Results: The mean age (years) of PAD subjects was 64.4 (${\pm}9.3$), while CAD subjects was 61.2 (${\pm}9.9$), and Control subjects was 59.9 (${\pm}9.1$) (p<0.01). The proportion of males was 90.6% for PAD, 71.4% for CAD, and 75.5% for Control subjects (p<0.01). The adjusted odds ratios (ORs) for hypertension, diabetes mellitus, hypercholesterolemia, smoking, metabolic syndrome and chronic kidney disease were significantly higher in subjects with PAD or CAD compared to those in Control. However, the ORs for high density lipoprotein, being overweight, and being obese were significantly lower in PAD subjects compared to those in Control. Conclusion: We found that cardiovascular risk factors were in fact risk factors for both PAD and CAD.

Keywords

References

  1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97. https://doi.org/10.1001/jama.285.19.2486
  2. Gornik HL, Creager MA. Contemporary management of peripheral arterial disease: I. Cardiovascular risk-factor modification. Cleve Clin J Med 2006;73 Suppl 4:S30-7.
  3. Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J 1999;20:344-53. https://doi.org/10.1053/euhj.1998.1194
  4. Gorter PM, Olijhoek JK, van der Graaf Y, Algra A, Rabelink TJ, Visseren FL; SMART Study Group. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis 2004;173:363-9.
  5. Kon V, Linton MF, Fazio S. Atherosclerosis in chronic kidney disease: the role of macrophages. Nat Rev Nephrol 2011;7:45-54. https://doi.org/10.1038/nrneph.2010.157
  6. Heuser RR. Treatment of lower extremity vascular disease: the Diamondback 360 degrees Orbital Atherectomy System. Expert Rev Med Devices 2008;5:279-86. https://doi.org/10.1586/17434440.5.3.279
  7. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999;100:1481-92. https://doi.org/10.1161/01.CIR.100.13.1481
  8. Haltmayer M, Mueller T, Horvath W, Luft C, Poelz W, Haidinger D. Impact of atherosclerotic risk factors on the anatomical distribution of peripheral arterial disease. Int Angiol 2001;20:200-7.
  9. Hozawa A, Okamura T, Murakami Y, et al. Joint impact of smoking and hypertension on cardiovascular disease and all-cause mortality in Japan: NIPPON DATA80, a 19-year follow-up. Hypertens Res 2007;30:1169-75. https://doi.org/10.1291/hypres.30.1169
  10. Eckel RH, Wassef M, Chait A, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation 2002;105:e138-43. https://doi.org/10.1161/01.CIR.0000013954.65303.C5
  11. Hatmi ZN, Mahdavi-Mazdeh M, Hashemi-Nazari SS, Hajighasemi E, Nozari B, Mahdavi A. Trend of lipid ratios associated with well known risk factors of coronary artery disease in different age: a population based study of 31,999 healthy individuals. Int J Cardiol 2011;151:328-32. https://doi.org/10.1016/j.ijcard.2010.06.007
  12. Higashiyama A, Okamura T, Ono Y, Watanabe M, Kokubo Y, Okayama A. Risk of smoking and metabolic syndrome for incidence of cardiovascular disease--comparison of relative contribution in urban Japanese population: the Suita study. Circ J 2009;73:2258-63. https://doi.org/10.1253/circj.CJ-09-0264
  13. Kokubo Y, Nakamura S, Okamura T, et al. Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study. Stroke 2009;40:2674-9. https://doi.org/10.1161/STROKEAHA.109.550707
  14. Bennett PC, Silverman S, Gill P. Hypertension and peripheral arterial disease. J Hum Hypertens 2009;23:213-5. https://doi.org/10.1038/jhh.2008.126
  15. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003;26:3333-41. https://doi.org/10.2337/diacare.26.12.3333
  16. Pasternak RC, Criqui MH, Benjamin EJ, et al. Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. Circulation 2004;109:2605-12. https://doi.org/10.1161/01.CIR.0000128518.26834.93
  17. Willigendael EM, Teijink JA, Bartelink ML, et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg 2004;40:1158-65. https://doi.org/10.1016/j.jvs.2004.08.049
  18. Tamura U, Tanaka T, Okamura T, et al. Changes in Weight, cardiovascular risk factors and estimated risk of coronary heart disease following smoking cessation in Japanese male workers: HIPOP-OHP study. J Atheroscler Thromb 2010;17:12-20. https://doi.org/10.5551/jat.1800
  19. Hwang YC, Jee JH, Oh EY, et al. Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans. Int J Cardiol 2009;134:313-21. https://doi.org/10.1016/j.ijcard.2008.12.025
  20. Carroll MD, Lacher DA, Sorlie PD, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005;294:1773-81. https://doi.org/10.1001/jama.294.14.1773
  21. Kim S, Popkin BM. Commentary: understanding the epidemiology of overweight and obesity--a real global public health concern. Int J Epidemiol 2006;35:60-7; discussion 81-2. https://doi.org/10.1093/ije/dyi255
  22. Bogers RP, Bemelmans WJ, Hoogenveen RT, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med 2007;167:1720-8. https://doi.org/10.1001/archinte.167.16.1720
  23. Barba R, Bisbe J, Pedrajas JN, et al. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry. Eur J Cardiovasc Prev Rehabil 2009;16:457-63. https://doi.org/10.1097/HJR.0b013e32832b1818
  24. Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC. Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. Am J Cardiol 2007;100:1331-5. https://doi.org/10.1016/j.amjcard.2007.06.019
  25. Diehm N, Shang A, Silvestro A, et al. Association of cardiovascular risk factors with pattern of lower limb atherosclerosis in 2659 patients undergoing angioplasty. Eur J Vasc Endovasc Surg 2006;31:59-63. https://doi.org/10.1016/j.ejvs.2005.09.006
  26. Brevetti G, Oliva G, Di Giacomo S, Bucur R, Annecchini R, Di Iorio A. Intermittent claudication in older patients: risk factors, cardiovascular comorbidity, and severity of peripheral arterial disease. J Am Geriatr Soc 2001;49:1261-2. https://doi.org/10.1046/j.1532-5415.2001.49248.x
  27. Ness J, Aronow WS, Newkirk E, McDanel D. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic. J Gerontol A Biol Sci Med Sci 2005;60:255-7. https://doi.org/10.1093/gerona/60.2.255
  28. Ozkan U, Oguzkurt L, Tercan F. Atherosclerotic risk factors and segmental distribution in symptomatic peripheral artery disease. J Vasc Interv Radiol 2009;20:437-41. https://doi.org/10.1016/j.jvir.2009.01.010
  29. Aboyans V, Criqui MH, Denenberg JO, Knoke JD, Ridker PM, Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 2006;113:2623-9. https://doi.org/10.1161/CIRCULATIONAHA.105.608679
  30. Criqui MH, Browner D, Fronek A, et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease. An analysis of risk factors. Am J Epidemiol 1989;129:1110-9. https://doi.org/10.1093/oxfordjournals.aje.a115233

Cited by

  1. Effect of obesity on functional outcomes at 6 months post-stroke among elderly Koreans: a prospective multicentre study vol.5, pp.12, 2013, https://doi.org/10.1136/bmjopen-2015-008712
  2. Long-term Survival Rates for Patients with Aortic Aneurysm vol.6, pp.1, 2013, https://doi.org/10.12997/jla.2017.6.1.22
  3. Survival Rates in Peripheral Artery Disease vol.6, pp.1, 2013, https://doi.org/10.12997/jla.2017.6.1.39
  4. 택시 운전자들을 위한 스마트폰 앱 기반 걷기운동 프로그램 개발 및 효과: Bandura의 자기효능이론을 중심으로 vol.50, pp.2, 2013, https://doi.org/10.4040/jkan.2020.50.2.242
  5. Serum apolipoprotein A-I concentration differs in coronary and peripheral artery disease vol.80, pp.5, 2013, https://doi.org/10.1080/00365513.2020.1746974
  6. Is Peripheral Artery Disease an Independent Predictor of Isolated Coronary Artery Bypass Outcome? vol.29, pp.10, 2013, https://doi.org/10.1016/j.hlc.2020.01.013
  7. Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease vol.41, pp.3, 2021, https://doi.org/10.1161/atvbaha.120.315828
  8. Prevalence of visceral artery involvement in patients with peripheral artery disease found on run-off MRA vol.21, pp.1, 2013, https://doi.org/10.1186/s12880-021-00615-2